New Facility to Detect and Respond to Outbreaks of Infectious Disease - WNEM TV 5

New Facility to Detect and Respond to Outbreaks of Infectious Disease

Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any questions or comments about this page please contact pressreleases@worldnow.com.

SOURCE Germfree Inc.

Advanced Disease Surveillance: Regional Lab Will Boost Global Biological Security

PORT OF SPAIN, Trinidad and Tobago, May 20, 2014 /PRNewswire/ -- A new biological containment laboratory has been officially handed over by the Government of Canada to the Caribbean Public Health Agency (CARPHA). The Biosafety Level 3 facility is the first of its kind for the Caribbean region. Manufactured by Germfree, the facility was provided by Canada to CARPHA in cooperation with the Pan American Health Organization (PAHO)/World Health Organization (WHO).  The lab will provide new capabilities to rapidly detect and respond to outbreaks of disease, whether naturally occurring or deliberately caused.

"In our modern age, where global travel is routine and disease knows no boundaries, a well-equipped, safe and secure biological laboratory is an essential tool in the fight against infectious disease," said His Excellency Mr. Gerard Latulippe, High Commissioner for Canada to Trinidad & Tobago, at the recent laboratory handover event. "As underscored by ongoing outbreaks of diseases such as the Chikungunya here in the Caribbean, as well as Ebola in West Africa, and the Middle East Respiratory Syndrome (MERS) in the Middle East, isolated disease threats can very quickly become regional or global menaces, presenting serious threats to the health, safety and security of the people of the world." 

The biocontainment facility is an initiative of the Biological Security program of Canada's Global Partnership Program (GPP), which "works to prevent terrorists and states of concern from acquiring or developing biological weapons and related materials, equipment, and technology." GPP's initiatives include programs to: "Detect and report deliberately caused disease by strengthening regional and sub-regional disease surveillance and detection networks, supporting the gathering of epidemic intelligence and broadening international disease reporting networks."

"When Germfree was approached by Canada's Global Partnership Program, we were excited to collaborate on this important international project. We worked closely with Canada's experts in biocontainment engineering and biosecurity," said Jeff Serle, General Manager of Germfree, US manufacturer of the lab. "GPP challenged us to be creative and innovative in our approach. Energy savings, maintainability and sustainability were key goals for the CARPHA lab."  

"Currently there are several public health events of international concern," said Dr. Yitades Gebre, Advisor on Family Health and Disease Management, PAHO/WHO. Dr. Gebre referred to reported outbreaks such as Chikungunya virus in the Caribbean, Ebola in West Africa and MERS Coronavirus in the Middle East when speaking at the laboratory handover. "In this regard, having proper laboratory support and services is paramount."

Developing the 'Health-Security Interface':  Threats to global health security can emerge as natural epidemics or deliberate biological attacks. The new biocontainment facility provides the capabilities required for both areas of concern. "A strong global partnership is required at the 'health-security interface', that broad area that exists between natural and deliberate disease," says Mr. Latulippe. "The tools, infrastructure and capacities required to accomplish both health and security objectives are the same."  Noting the global impact of regional labs, The High Commissioner added, "No country or region, irrespective of its size or location, is immune to these challenges."

The biocontainment lab is set up to rapidly identify samples suspected for a diverse range of diseases – including Yellow fever, West Nile virus, Rabies, Hantavirus, Anthrax, drug resistant MTB and emerging infectious diseases with epidemic potential. Advanced containment systems allow personnel to handle other biological-risk agents and materials of unknown origin. Regional biocontainment laboratories play a critical international role. According to Dr. C. James Hospedales, Executive Director of CARPHA, "This is a strategic public health resource for the Americas and the world." 

Related Links:
www.germfree.com/backgrounder 
www.germfree.com/media 

©2012 PR Newswire. All Rights Reserved.

Powered by WorldNow
WNEM
Powered by WorldNow CNN
All content © 2014, WNEM; Saginaw, MI. (A Meredith Corporation Station) and WorldNow. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service.